Pfizer's Prevnar 7 vaccine, which protects against pneumonia and meningitis, has been shown to reduce the risk of recurrent pneumococcal infection in patients living with HIV in Malawi, according to a study published Thursday in the New England Journal of Medicine, Reuters reports. "In HIV-infected patients, particularly in sub-Saharan Africa, the risk of developing [invasive pneumococcal ...
Last Updated:Monday, 08 March 2010 13:06:33 GMT
Read Full Story
